Women with twin pregnancies should not be given prophylactic cerclage simply because they are carrying two fetuses. A 14-year retrospective study of twins using data from Matria Healthcare indicates that prophylactic cerclage is associated with a higher frequency of very premature delivery, low birth weight and very low birth weight infants, and more nursery days
Women with twin pregnancies should not be given prophylactic cerclage simply because they are carrying two fetuses. A 14-year retrospective study of twins using data from Matria Healthcare indicates that prophylactic cerclage is associated with a higher frequency of very premature delivery, low birth weight and very low birth weight infants, and more nursery days.
Andrei Rebarber, MD, and a team from NYU University Hospital in New York City combed the Matria Healthcare records of outpatient preterm labor surveillance between 1990 and 2004. The group compared twin pregnancies with and without prophylactic cerclage. Women with previous preterm deliveries or a diagnosis of cervical incompetence in a previous or the index pregnancy were excluded.
Of the 8,168 twin pregnancies that met inclusion criteria, 146, or 1.8%, received prophylactic cerclage. The incidence of delivery before 32 weeks was 19.2% in the prophylactic cerclage group compared to 12.1% in the non-cerclage group (P=0.014). Median birth weights were lower, 2,140 g compared to 2,310 g (P=0.001) for those without a cerclage. The cerclage group had 13.7 nursery days versus 11.7 days for the noncerclage group (P=0.012). Citing the risks involved, researches recommended against the use of prophylactic cerclage for the sole indication of twin pregnancy.
Rebarber R, Roman A, Saltzman D, Laughon SK, Rhea D. Prophylactic cerclage in the management of twin pregnancies. Obstet Gynecol. 2005;105(4 suppl):114S.
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
No link found between prenatal cannabis use and childhood developmental delay
November 5th 2024In a recent study, offspring of women with cannabis use in early pregnancy confirmed by self-report or toxicology test were not at an increased risk of childhood early developmental delay up to the age of 5.5 years.
Read More
Prenatal cannabis use not linked to offspring ASD development
November 1st 2024In a recent study, adjustments for maternal characteristics mediated the association between maternal prenatal cannabis use and offspring autism spectrum disorder, indicating no statistically significant increase in risk.
Read More
Importance of reproductive health services for adolescents during the COVID-19 pandemic
October 30th 2024In a recent study, high rates of reproductive health service use were reported among adolescent mothers, indicating the benefits of this model for providing care when other options are unavailable.
Read More